Table 3.
Frequency of presentation of patients with pooled immune-mediated diseases.
| Variables | Autoimmune gastritis (n=60) | Controls (n=30) | Odds ratioa | 95%CI | p value |
|---|---|---|---|---|---|
| I. Pooled immune-mediated diseases n (%)b | |||||
| Including immune thyroid diseasec | 42 (70.0) | 8 (26.7) | 11.67 | 3.49–39.05 | <0.001 |
| Excluding immune thyroid disease | 23 (38.3) | 4 (13.3) | 5.55 | 1.53–20.17 | 0.009 |
| II. Pooled mucocutaneous immune-mediated diseases n (%)d | |||||
| Including immune thyroid disease | 40 (66.7) | 7 (23.3) | 12.02 | 3.51–41.13 | <0.001 |
| Excluding immune thyroid disease | 18 (30.0) | 3 (10.0) | 4.75 | 1.18–19.16 | 0.029 |
| III. Investigational hypotheses n (%)e | 15 (25.0) | 2 (6.7) | 6.82 | 1.27–36.72 | 0.025 |
Odds ratio adjusted for sex, age, H. pylori, tobacco use and alcohol consumption. Significance p<0.05.
“Pooled immune-mediated diseases”: vitiligo, alopecia areata, lichen planus, Sjögren’s syndrome, urticaria, lupus, dermatomyositis, scleroderma, morphea, lichen sclerosus, vasculitis, panniculitis, psoriasis, hidradenitis suppurativa, immune arthritis, type 1 diabetes mellitus, adrenal insufficiency, coeliac disease and polymyalgia rheumatica.
Immune thyroid disease: Hashimoto’s thyroiditis and hyperthyroidism.
“Pooled mucocutaneous immune-mediated diseases”: vitiligo, alopecia areata, lichen planus, Sjögren’s syndrome, urticaria, lupus, dermatomyositis, scleroderma, morphea, lichen sclerosus, vasculitis, panniculitis, psoriasis and hydradenitis suppurativa.
“Investigation hypothesis”: vitiligo, alopecia areata, Sjögren’s syndrome and coeliac disease.